
Philippe Genereux MD
Co-Director, Structural Heart Disease, Morristown Medical Center
Join to View Full Profile
100 Madison AvenueBox 5Morristown, NJ 07960
Dr. Genereux is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
 - Connect with colleagues in the same hospital or clinic.
 - Read the latest clinical news, personalized to your specialty.
 
Education & Training
New York Presbyterian Hospital (Columbia Campus)Post-Doctoral Fellowship, Interventional Cardiology, 2008 - 2010
University of Montreal Faculty of MedicineClass of 2001
Certifications & Licensure
NY State Medical License 2008 - Present
NJ State Medical License 2016 - 2027
Clinical Trials
- BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY Start of enrollment: 2016 Apr 01
 - EARLY TAVR: Evaluation of TAVR Compared to Surveillance for Patients With Asymptomatic Severe Aortic Stenosis Start of enrollment: 2017 Jul 12
 - Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial Start of enrollment: 2017 Mar 27
 - Join now to see all
 
Publications & Presentations
PubMed
- Favorable Effects of Atrial Fixation Transcatheter Mitral Valve Replacement on Left Atrium Volume and Strain.Nadira Hamid, Paul Grayburn, Vlasis Ninios, Krzysztof Wrobel, Naeem Tahirkheli
JACC. Advances. 2025-10-16 - 1 citationsIntravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions: The ECLIPSE Trial.Gregg W Stone, Philippe Genereux, Akiko Maehara, Bruce E Lewis, Richard A Shlofmitz
JACC. Cardiovascular Interventions. 2025-10-13 - A Comprehensive Review of Left Atrial Venoarterial Extracorporeal Membrane Oxygenation.Ahmad Jabri, Sant Kumar, Al Muthanna Shadid, Harish Ramakrishna, Gennaro Giustino
Journal of Cardiothoracic and Vascular Anesthesia. 2025-09-01 
Journal Articles
- Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
 - Original Investigation Left Main Revascularization with PCI or CABG in Patients with Chronic Kidney Disease: EXCEL TrialJohn D Puskas, David E Kandzari, Gennaro Giustino, Roxana Mehran, Martin B Leon, Philippe Genereux, Michael 3rd Ragosta, Charles A Simonton, Irving L Kron, Gregg W Stone, ScienceDirect
 
Lectures
- Real-Time Bleed Detection: Novel Saranas Early Bird Bleed MonitoringCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
 - Making the Case for… - Rationale and Trial UpdatesCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
 - The Pi-Cardia Leaflex Aortic Valve Remodeling SystemCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
 - Join now to see all
 
Authored Content
- Clinical Investigations the East–West Late Lumen Loss Study: Comparison of Angiographic Late Lumen Loss Between Eastern and Western Drug-Eluting Stent Study CohortsOctober 2018
 - High on-Treatment Platelet Reactivity and Outcome in Elderly with Non ST-Segment Elevation Acute Coronary Syndrome - Insight from the GEPRESS StudyMarch 2018
 
Press Mentions
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical OutcomesMay 22nd, 2025
FDA Approves Sapien 3 TAVR for Asymptomatic Severe Aortic StenosisMay 5th, 2025
Younger Patients with Asymptomatic Aortic Stenosis Who Undergo TAVR Experience Fewer Serious Cardiovascular EventsMay 2nd, 2025- Join now to see all
 
Other Languages
- French
 
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









